A coalition of researchers has initiated multicenter studies to standardize epigenetic age measurements, aiming to enhance cancer risk stratification through evidence-based protocols. Growing concerns about the links between accelerated epigenetic aging and negative colorectal cancer outcomes underscore the urgent need for clinical guidelines and robust data-sharing frameworks. As this initiative aligns mechanistic insights with clinical realities, it promises to facilitate earlier interventions while addressing the risks of premature application.